ProfileGDS4718 / 226769_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 53% 97% 34% 46% 44% 55% 44% 59% 45% 47% 47% 46% 65% 50% 51% 52% 64% 48% 63% 53% 52% 54% 55% 44% 65% 52% 53% 45% 40% 45% 82% 51% 42% 81% 76% 40% 53% 40% 98% 50% 50% 97% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2036744
GSM549102patient 115, normal, homogenized [OPG study]5.6864553
GSM549104patient 119, normal, homogenized [OPG study]10.773697
GSM549108patient 138, normal, homogenized [OPG study]4.7716434
GSM549119patient 077, normal, homogenized [OPG study]5.2963246
GSM549133patient 032, cancer, homogenized [OPG study]5.1231644
GSM549139patient 042, cancer, homogenized [OPG study]5.7902255
GSM549099patient 107, normal, homogenized [OPG study]5.1967844
GSM549109patient 139, normal, homogenized [OPG study]6.059359
GSM549110patient 046, normal, homogenized [OPG study]5.2533845
GSM549114patient 063, normal, homogenized [OPG study]5.2847747
GSM549122patient 082, normal, homogenized [OPG study]5.3559647
GSM549134patient 033, cancer, homogenized [OPG study]5.281446
GSM549136patient 036, cancer, homogenized [OPG study]6.4808165
GSM549140patient 044, cancer, homogenized [OPG study]5.4587450
GSM549111patient 047, normal, homogenized [OPG study]5.5563851
GSM549113patient 057, normal, homogenized [OPG study]5.6061652
GSM549132patient 031, cancer, homogenized [OPG study]6.4255364
GSM549137patient 038, cancer, homogenized [OPG study]5.4155948
GSM549142patient 047, cancer, homogenized [OPG study]6.3953563
GSM549100patient 110, normal, homogenized [OPG study]5.6935553
GSM549107patient 135, normal, homogenized [OPG study]5.6052452
GSM549115patient 068, normal, homogenized [OPG study]5.7138354
GSM549116patient 072, normal, homogenized [OPG study]5.8140755
GSM549120patient 078, normal, homogenized [OPG study]5.1985844
GSM549131patient 030, cancer, homogenized [OPG study]6.4762565
GSM549118patient 074, normal, homogenized [OPG study]5.6140152
GSM549129patient 027, cancer, homogenized [OPG study]5.714553
GSM549123patient 088, normal, homogenized [OPG study]5.2222745
GSM549124patient 006, cancer, homogenized [OPG study]5.022840
GSM549126patient 015, cancer, homogenized [OPG study]5.2373545
GSM549128patient 025, cancer, homogenized [OPG study]8.1242382
GSM549103patient 117, normal, homogenized [OPG study]5.6255251
GSM549117patient 073, normal, homogenized [OPG study]5.0751442
GSM549138patient 041, cancer, homogenized [OPG study]7.9789381
GSM549141patient 045, cancer, homogenized [OPG study]7.5712976
GSM549130patient 028, cancer, homogenized [OPG study]4.9937140
GSM549101patient 111, normal, homogenized [OPG study]5.7170353
GSM549105patient 128, normal, homogenized [OPG study]5.0016340
GSM549106patient 134, normal, homogenized [OPG study]11.542698
GSM549112patient 048, normal, homogenized [OPG study]5.499750
GSM549125patient 011, cancer, homogenized [OPG study]5.5325250
GSM549127patient 024, cancer, homogenized [OPG study]10.583897
GSM549135patient 035, cancer, homogenized [OPG study]5.4439949